Clinical Trials Directory

Trials / Completed

CompletedNCT03557593

Optimizing Prescribing of Antipsychotics in Long-Term Care

Optimizing Prescribing of Antipsychotics in Long-Term Care (OPAL): A Randomized Trial to Reduce Inappropriate Antipsychotic Prescribing in Long-Term Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
Sponsor
Queen's University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Not accepted

Summary

Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC. A multi component intervention to reduce inappropriate antipsychotic prescribing was evaluated in ten Canadian long-term care facilities.

Detailed description

Increasing numbers of older adults are affected by dementia, and many will eventually reside in long-term care (LTC), where antipsychotic use is relatively common. Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC but limited evidence exists on the most effective strategies for reducing inappropriate antipsychotic use. The objective of the study was to evaluate a multicomponent approach to reduce inappropriate prescribing of antipsychotics in LTC. A prospective, randomized stepped-wedge, study design was used to evaluate the effect of the intervention in 10 LTC facilities in Canada. The intervention consisted of an educational in-service, provision of evidence-based tools to assess and monitor neuropsychiatric symptoms (NPS) and monthly interprofessional team meetings.

Conditions

Interventions

TypeNameDescription
OTHEREducationalMulti component educational intervention in long-term care

Timeline

Start date
2016-01-01
Primary completion
2017-10-01
Completion
2017-12-01
First posted
2018-06-15
Last updated
2018-06-26

Source: ClinicalTrials.gov record NCT03557593. Inclusion in this directory is not an endorsement.